Literature DB >> 21458216

Comparison of the Constipation Assessment Scale and plain abdominal radiography in the assessment of constipation in advanced cancer patients.

Kittiphon Nagaviroj1, Woon Chai Yong, Konrad Fassbender, George Zhu, Doreen Oneschuk.   

Abstract

CONTEXT: Constipation is a distressing condition for advanced cancer patients and is frequently underdiagnosed.
OBJECTIVES: The primary objective of this study was to determine if a strong correlation existed between the use of the Constipation Assessment Scale (CAS) and a plain abdominal radiograph in the interpretation of constipation in patients with advanced cancer. The secondary aim of the study was to compare the plain film radiographic constipation scores among three palliative medicine physicians.
METHODS: The study was a prospective cross-sectional study of 50 advanced cancer patients admitted to a tertiary palliative care unit. These patients completed the CAS shortly after their admission to the unit. Around the same time, they underwent a flat plate of abdomen that was scored from 0 to 12, based on the amount of stool in the colon, by three palliative medicine physicians who were blinded to the CAS results and each other's radiographic interpretations. Kendall Tau correlation coefficient was used to estimate and test the correlations between the CAS and radiographic constipation scores.
RESULTS: There was no concordant correlation between the CAS scores and each physician's radiographic constipation score. There also was no concordant correlation between the CAS score and the combined radiographic constipation scores of the three palliative medicine physicians (Kendall Tau coefficient=0.04; P=0.72). The degree of correlation between the radiographic constipation scores from the three palliative medicine physicians was moderate.
CONCLUSION: Our study failed to yield a strong correlation between the CAS and the plain abdominal radiographic scores for constipation completed by three palliative medicine physicians. It is advisable that constipation in advanced cancer patients be assessed both clinically and radiographically.
Copyright © 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21458216     DOI: 10.1016/j.jpainsymman.2010.11.019

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  5 in total

1.  A pragmatic comparative study of palliative care clinician's reports of the degree of shadowing visible on plain abdominal radiographs.

Authors:  Katherine Clark; L Lam; N J Talley; G Watts; J L Phillips; N J Byfieldt; D C Currow
Journal:  Support Care Cancer       Date:  2018-05-07       Impact factor: 3.603

2.  Response to Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A (2020) MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 28:23.

Authors:  Katherine Clark; David C Currow
Journal:  Support Care Cancer       Date:  2020-01-10       Impact factor: 3.603

3.  Self-reported constipation in patients with advanced cancer: a preliminary report.

Authors:  Wadih Rhondali; Linh Nguyen; Lynn Palmer; Duck-Hee Kang; David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-07-25       Impact factor: 3.612

4.  Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: a randomized controlled clinical trial.

Authors:  Akiko Hanai; Hiroshi Ishiguro; Takashi Sozu; Moe Tsuda; Hidenori Arai; Akira Mitani; Tadao Tsuboyama
Journal:  Breast Cancer Res Treat       Date:  2015-12-09       Impact factor: 4.872

5.  Effects of Yeast Mannan Which Promotes Beneficial Bacteroides on the Intestinal Environment and Skin Condition: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Reiko Tanihiro; Katsuhisa Sakano; Shunsuke Oba; Chikako Nakamura; Kohji Ohki; Tatsuhiko Hirota; Hiroshi Sugiyama; Shukuko Ebihara; Yasunori Nakamura
Journal:  Nutrients       Date:  2020-11-28       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.